HeartFlow Inc HTFL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
AHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE Registry
TCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of Patients
Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026
Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half
Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference
Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Trading Information
- Previous Close Price
- $51.95
- Day Range
- $51.06–53.49
- 52-Week Range
- $20.13–60.56
- Bid/Ask
- $51.25 / $53.98
- Shares Outstanding
- 86.95M
- Market Cap
- $4.56B
- Volume/Avg
- 969,877 / 2M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 9.11
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
HeartFlow Inc is a commercial-stage medical technology company that provides software and artificial intelligence (AI) designed to deliver a non-invasive solution for diagnosing and managing coronary artery disease. The company operates and manages its business as a single reportable operating segment: non-invasive coronary artery disease detection solutions. Geographically, it operates in the United States and the rest of Europe, deriving the majority of its revenue from the United States. The company has developed three software products: Heartflow Roadmap Analysis, Heartflow FFRCT Analysis, and Heartflow Plaque Analysis.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Growth
- Total Number of Employees
- 843
- Website
- https://www.heartflow.com
Valuation
Metric | HTFL |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 16.24 |
Price/Sales | 9.11 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | HTFL |
|---|---|
Quick Ratio | 4.66 |
Current Ratio | 5.08 |
Interest Coverage | −35.85 |
Quick Ratio
HTFL
Profitability
Metric | HTFL |
|---|---|
Return on Assets (Normalized) | −13.28% |
Return on Equity (Normalized) | −92.44% |
Return on Invested Capital (Normalized) | −44.88% |
Return on Assets
HTFL
Health Information Services Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Veeva Systems Inc Class A VEEV | LOCK|@%lTTrl! | LOCK|bPT | $49B | |||
| Pro Medicus Ltd ADR PMDIY | — | LOCK|YS$>@ | $15B | |||
| Pro Medicus Ltd PMCUF | — | LOCK|tp>? | $15B | |||
| Tempus AI Inc Class A common stock TEM | — | LOCK|d@d | $14B | |||
| BrightSpring Health Services Inc BTSG | — | LOCK|x!K> | $13B | |||
| Hinge Health Inc Ordinary Shares - Class A HNGE | — | LOCK|M>sDf | $9B | |||
| HealthEquity Inc HQY | — | LOCK|@<dS | $9B | |||
| M3 Inc MTHRF | — | LOCK|&wmxV | $8B | |||
| M3 Inc ADR MTHRY | — | LOCK|$n>S | $8B | |||
| Doximity Inc Class A DOCS | — | LOCK|WvY% | $6B |
United States